Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
30.8M
-
Shares change
-
+2.96M
-
Total reported value, excl. options
-
$787M
-
Value change
-
+$74.4M
-
Number of buys
-
48
-
Number of sells
-
-29
-
Price
-
$25.52
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q4 2020
95 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q4 2020.
Avidity Biosciences, Inc. - Common Stock (RNA) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.8M shares
of 120M outstanding shares and own 25.66% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4M shares), FMR LLC (3.42M shares), Cormorant Asset Management, LP (2.46M shares), EcoR1 Capital, LLC (2.1M shares), BlackRock Inc. (2.03M shares), ALETHEA CAPITAL MANAGEMENT, LLC (1.57M shares), FEDERATED HERMES, INC. (1.43M shares), PERCEPTIVE ADVISORS LLC (1.24M shares), Matrix Capital Management Company, LP (1.2M shares), and BOXER CAPITAL, LLC (1.12M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.